[1]
|
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A. and Bray, F. (2021) Globalcancer Statis-tics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA, 71, 209-249. https://doi.org/10.3322/caac.21660
|
[2]
|
Crook, T., Gaya, A., Page, R., Limaye, S., Ranade, A., Bhatt, A., Patil, S., Kumar, P., Patil, D. and Akolkar, D. (2021) Clinical Utility of Circulating Tumor-Associated Cells to Predict and Monitor Chemo-Response in Solid Tumors. Cancer Chemotherapy and Pharmacology, 87, 197-205. https://doi.org/10.1007/s00280-020-04189-8
|
[3]
|
Levy, I. and Gralnek, I.M. (2016) Complications of Diagnostic Colonoscopy, Upper Endoscopy and Enteroscopy. Best Practice & Research Clinical Gastroenterology, 30, 705-718. https://doi.org/10.1016/j.bpg.2016.09.005
|
[4]
|
于纯良, 赵红. ctDNA在胃癌的研究进展[J]. 世界最新医学信息文摘, 2019, 19(37): 130-132.
|
[5]
|
Yu, M., Stott, S., Toner, M., Maheswaran, S. and Haber, D.A. (2011) Circulating Tumor Cells: Approaches to Isolation and Characterization. The Journal of Cell Biology, 192, 373-382. https://doi.org/10.1083/jcb.201010021
|
[6]
|
Ashworth, T.R. (1869) A Case of Cancer in Which Cells Similar to Those in the Tumors Were Seen in the Blood after Death. Medical Journal of Australia, 14, 146.
|
[7]
|
Lin, D., Shen, L., Luo, M., et al. (2021) Circulating Tumor Cells: Biology and Clinical Significance. Signal Transduction and Targeted Therapy, 6, Article No. 24. https://doi.org/10.1038/s41392-021-00817-8
|
[8]
|
张同梅, 李宝兰. 循环肿瘤细胞检测技术的研究进展[J]. 中华诊断学电子杂志, 2017, 5(1): 62-66.
|
[9]
|
李敏, 豆小文, 刘丹, 等. imFISH循环肿瘤细胞检测结果与恶性肿瘤患者临床特征及预后的关系[J]. 国际检验医学杂志, 2022(13): 1541-1545, 1551.
|
[10]
|
Rawla, P. and Barsouk, A. (2018) Epidemiology of Gastric Cancer: Global Trends, Risk Factors and Preven-tion. Przegląd Gastroenterologiczny, 14, 26-38. https://doi.org/10.5114/pg.2018.80001
|
[11]
|
明星, 胡荍, 谢多双, 等. 食管鳞癌循环肿瘤细胞在新辅助放化疗中动态变化及预后意义[J]. 中华肿瘤防治杂志, 2017, 24(8):565-565.
|
[12]
|
钟光华, 刘丽贤, 朱晓慧, 等. 循环肿瘤细胞检测在预测非小细胞肺癌化疗疗效中的应用[J]. 实用癌症杂志, 2017, 32(9): 1521-1523.
|
[13]
|
付汉东, 寇继光, 刘汉中, 张爱华, 王雪菲, 阳仕雄, 胡校云, 沈婷, 鲁艳, 魏威. 循环肿瘤细胞检测对胃癌新辅助化疗疗效的评估价值[J]. 广东药科大学学报, 2019, 35(5): 693-696.
https://doi.org/10.16809/j.cnki.2096-3653.2019071707
|
[14]
|
Liu, Y., Ling, Y., Qi, Q., et al. (2017) Prognostic Value of Circulating Tumor Cells in Advanced Gastric Cancer Patients Receiving Chemotherapy. Molecular & Clinical Oncology. https://doi.org/10.3892/mco.2017.1125
|
[15]
|
王刘星, 杨弘鑫, 戴礼, 等. 循环肿瘤细胞与胃癌患者临床病理特征及预后相关性分析[J]. 重庆医学, 2023, 52(3): 326-332.
|
[16]
|
Kang, Y. and Pantel, K. (2013) Tumor Cell Dissemination: Emerging Biological Insights from Animal Models and Cancer Patients. Cancer Cell, 23, 573-581. https://doi.org/10.1016/j.ccr.2013.04.017
|
[17]
|
Ito, H., Inoue, H., Sando, N., et al. (2012) Prognostic Impact of De-tecting Viable Circulating Tumour Cells in Gastric Cancer Patients Using a Telomerase-Specific Viral Agent: A Prospec-tive Study. BMC Cancer, 12, Article No. 346.
https://doi.org/10.1186/1471-2407-12-346
|
[18]
|
Tellez-Gabriel, M., Heymann, M.F. and Heymann, D. (2019) Cir-culating Tumor Cells as a Tool for Assessing Tumor Heterogeneity. Theranostics, 9, 4580-4594. https://doi.org/10.7150/thno.34337
|
[19]
|
Miller, K.D., Sauer, A.G., et al. (2018) Cancer Statistics for Hispan-ics/Latinos, 2018. CA, 68, 425-455.
https://doi.org/10.3322/caac.21494
|
[20]
|
Ni, C., Shen, Y., Fang, Q., et al. (2020) Prospective Study of the Rele-vance of Circulating Tumor Cell Status and Neoadjuvant Chemotherapy Effectiveness in Early Breast Cancer. Cancer Medicine, 9, 2290-2298.
https://doi.org/10.1002/cam4.2876
|
[21]
|
Riethdorf, S., Müller, V., Loibl, S., et al. (2017) Prognostic Impact of Cir-culating Tumor Cells for Breast Cancer patients Treated in the Neoadjuvant “Geparquattro” Trial. Clinical Cancer Re-search, 23, 5384-5393.
https://doi.org/10.1158/1078-0432.CCR-17-0255
|
[22]
|
Kasimir-Bauer, S., Bittner, A.K., König, L., et al. (2016) Does Primary Neoadjuvant Systemic Therapy Eradicate Minimal Residual Disease?: Analysis of Disseminated and Cir-culating Tumor Cells before and after Therapy. Breast Cancer Research, 18, 20.
|
[23]
|
Yu, M., Bardia, A. and Wittner, B.S. (2013) Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition. Breast Diseases: A Year Book Quarterly, 24, 225-226.
https://doi.org/10.1016/j.breastdis.2013.07.021
|
[24]
|
单海琳, 苏瑛, 周斌, 等. 血循环肿瘤细胞检测在中晚期乳腺癌疗效评价及转移监测中的应用[J]. 标记免疫分析与临床, 2017, 24(9): 998-991, 997.
|
[25]
|
郝帅, 田武国, 高博, 等. 循环肿瘤细胞检测在乳腺癌新辅助化疗疗效评估中的价值[J]. 中华乳腺病杂志(电子版), 2017, 11(1): 6-12.
|
[26]
|
杜静怡, 徐兴祥, 卞家蓉. 外周血循环肿瘤细胞在晚期肺鳞癌患者免疫联合化疗疗效及预后中的价值初探[J]. 中国现代医药杂志, 2021, 23(3): 9-14.
|
[27]
|
刘少博, 黄波. 基于生物信息学方法识别肺腺癌预后相关基因及预后风险模型的构建[J]. 中国免疫学杂志, 2021, 37(23): 2880-2892.
|
[28]
|
李颖佳, 陈辉, 廖金凤, 等. 循环肿瘤细胞用于监测非小细胞肺癌新辅助免疫综合治疗疗效的临床研究[J]. 中华预防医学杂志, 2021, 55(2): 233-238.
|
[29]
|
闵梦云, 尹宜发, 赵新程, 等. 循环肿瘤细胞在肺癌中的临床研究进展[J]. 肿瘤学杂志, 2018, 24(1): 6-10.
|
[30]
|
Tong, B., Xu, Y., Zhao, J., et al. (2018) Prognostic Role of Circulating Tumor Cells in Patients with EGFR-Mutated or ALK-Rearranged Non-Small Cell Lung Cancer. Thoracic Cancer, 9, 640-645.
https://doi.org/10.1111/1759-7714.12631
|
[31]
|
Zhang, F., Wu, X., Zhu, J., et al. (2021) 18F-FDG PET/CT and Circulating Tumor Cells in Treatment-Naive Patients with Non-Small-Cell Lung Cancer. European Journal of Nuclear Medicine and Molecular Imaging, 48, 3250-3259.
https://doi.org/10.1007/s00259-021-05260-zV
|
[32]
|
Tartarone, A., Rossi, E., Lerose, R., et al. (2017) Possible Ap-plications of Circulating Tumor Cells in Patients with Non Small Cell Lung Cancer. Lung Cancer, 107, 59-74. https://doi.org/10.1016/j.lungcan.2016.05.027
|
[33]
|
Marianna, G., Antonella, D.L., Rosaria, M.M., et al. (2017) Clinical Utility of Circulating Tumor Cells in Patients with Non-Small-Cell Lung Cancer. Translational Lung Cancer Research, 6, 486-498.
https://doi.org/10.21037/tlcr.2017.05.07
|